- Hans-Georg
Rammensee (born 12
April 1953) is a
German immunologist and
cancer researcher. He has been
Chair Professor and Head of the
Department of Immunology...
-
Pascolo (CSO),
Florian von der
Mulbe (COO), Günther Jung, and Hans-Georg
Rammensee.
CureVac has had
approximately 375
employees since May 2018. At the beginning...
- Jung,
Institute of
Organic Chemistry, in
cooperation with Hans-Georg
Rammensee,
Institute of
Immunology and Cell
Biology (both:
University of Tübingen)...
- PMID 16255049. Mear, J. P.; Schreiber, K. L.; Münz, C.; Zhu, X.; Stevanović, S.;
Rammensee, H. G.; Rowland-Jones, S. L.; Colbert, R. A. (1999-12-15). "Misfolding...
- for
cancer treatment and vaccines) was
conducted by
groups led by H. G.
Rammensee and G. Jung. This work
contributed to the Ph.D. and
later research of...
-
Retrieved 20
December 2020.
Probst J,
Weide B,
Scheel B,
Pichler BJ, ****r I,
Rammensee HG,
Pascolo S (August 2007). "Spontaneous
cellular uptake of exogenous...
- 3171/2013.2.FOCUS1313. PMID 23634918. Haen SP,
Pereira PL,
Salih HR,
Rammensee HG,
Gouttefangeas C (2011). "More Than Just
Tumor Destruction: Immunomodulation...
- the project's
multiple vaccine candidates. In
March 2020, Hans-Georg
Rammensee,
professor of
immunology at
University of Tübingen and co-founder of CureVac...
- 2014.03.04. PMC 4115762. PMID 25083502. Haen SP,
Pereira PL,
Salih HR,
Rammensee HG,
Gouttefangeas C (2011). "More Than Just
Tumor Destruction: Immunomodulation...
-
Stevanovic in
cooperation with the cell-biological
group of Hans-Georg
Rammensee. The
elaborated analytical protocols are
essential for the elucidation...
